NI201100113A - Derivados bicíclicos de morfina - 6 - glucuronido, su preparación y su aplicación en terapeutica. - Google Patents

Derivados bicíclicos de morfina - 6 - glucuronido, su preparación y su aplicación en terapeutica.

Info

Publication number
NI201100113A
NI201100113A NI201100113A NI201100113A NI201100113A NI 201100113 A NI201100113 A NI 201100113A NI 201100113 A NI201100113 A NI 201100113A NI 201100113 A NI201100113 A NI 201100113A NI 201100113 A NI201100113 A NI 201100113A
Authority
NI
Nicaragua
Prior art keywords
therapeutics
application
group
glucuronide
morphine
Prior art date
Application number
NI201100113A
Other languages
English (en)
Inventor
Dlubala Alain
Ripoche Isabelle
Trecant Claire
Original Assignee
Aplicaciones Terapeuticas En El Dominio Cardiovascular De Derivados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Terapeuticas En El Dominio Cardiovascular De Derivados filed Critical Aplicaciones Terapeuticas En El Dominio Cardiovascular De Derivados
Publication of NI201100113A publication Critical patent/NI201100113A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invención tiene por objeto los compuestos que responden a la fórmula (I) en la que: R 1 representa un átomo de hidrógeno o un grupo alquilo(C1-C4), R2 representa un grupo hidroxilo, un grupo tiol, un grupo alquiloxi(C1-C4) o un grupo tioalquilo(C1 -C4), y n es un número entero igual a 1 ó 2, en el estado de base o de sal de adición a un ácido así como en el estado de hidrato o de solvato. La presente invención pretende igualmente su procedimiento de preparación y su aplicación en terapéutica.
NI201100113A 2008-12-11 2011-06-08 Derivados bicíclicos de morfina - 6 - glucuronido, su preparación y su aplicación en terapeutica. NI201100113A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806974A FR2939796B1 (fr) 2008-12-11 2008-12-11 Derives bicycliques de morphine-6-glucuronide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
NI201100113A true NI201100113A (es) 2011-12-15

Family

ID=41037668

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201100113A NI201100113A (es) 2008-12-11 2011-06-08 Derivados bicíclicos de morfina - 6 - glucuronido, su preparación y su aplicación en terapeutica.

Country Status (33)

Country Link
US (1) US8440634B2 (es)
EP (1) EP2376511B1 (es)
JP (1) JP5616355B2 (es)
KR (1) KR20110091536A (es)
CN (1) CN102317302B (es)
AR (1) AR074578A1 (es)
AU (1) AU2009326907B2 (es)
BR (1) BRPI0923368A2 (es)
CA (1) CA2746701A1 (es)
CL (1) CL2011001401A1 (es)
CO (1) CO6382159A2 (es)
CR (1) CR20110317A (es)
EA (1) EA201170791A1 (es)
EC (1) ECSP11011107A (es)
ES (1) ES2470684T3 (es)
FR (1) FR2939796B1 (es)
HK (1) HK1163109A1 (es)
HN (1) HN2011001614A (es)
IL (1) IL213380A (es)
MA (1) MA32954B1 (es)
ME (1) ME01147B (es)
MX (1) MX2011006251A (es)
MY (1) MY153779A (es)
NI (1) NI201100113A (es)
NZ (1) NZ593340A (es)
PE (1) PE20120231A1 (es)
SG (1) SG172070A1 (es)
SV (1) SV2011003937A (es)
TN (1) TN2011000277A1 (es)
TW (1) TW201026313A (es)
UA (1) UA104445C2 (es)
WO (1) WO2010067008A2 (es)
ZA (1) ZA201104389B (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
WO1998046618A1 (en) * 1997-04-14 1998-10-22 Salford Ultrafine Chemicals And Research Ltd. Morphine derivatives
HUP0100841A3 (en) * 1998-02-02 2003-03-28 Cenes Ltd Cambridge Glycosidation of 4,5-epoxymorphinan-6-ols
IL139773A0 (en) 1998-06-06 2002-02-10 Cenes Ltd Morphine-6-glucuronide synthesis
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
DE10229842A1 (de) * 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
US8481501B2 (en) * 2004-05-28 2013-07-09 Human Biomolecular Research Institute Synthesis of metabolically stable analgesics, pain medications and other agents
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques

Also Published As

Publication number Publication date
FR2939796B1 (fr) 2010-12-17
ECSP11011107A (es) 2011-07-29
WO2010067008A3 (fr) 2011-07-07
MY153779A (en) 2015-03-13
UA104445C2 (uk) 2014-02-10
EA201170791A1 (ru) 2012-01-30
FR2939796A1 (fr) 2010-06-18
MX2011006251A (es) 2011-11-18
ME01147B (me) 2012-12-20
TW201026313A (en) 2010-07-16
SG172070A1 (en) 2011-07-28
EP2376511B1 (fr) 2014-03-12
BRPI0923368A2 (pt) 2019-09-24
CL2011001401A1 (es) 2011-10-28
MA32954B1 (fr) 2012-01-02
EP2376511A2 (fr) 2011-10-19
ZA201104389B (en) 2012-09-26
TN2011000277A1 (fr) 2012-12-17
JP5616355B2 (ja) 2014-10-29
US20110275580A1 (en) 2011-11-10
CO6382159A2 (es) 2012-02-15
AR074578A1 (es) 2011-01-26
AU2009326907B2 (en) 2016-05-26
PE20120231A1 (es) 2012-04-04
HK1163109A1 (en) 2012-09-07
ES2470684T3 (es) 2014-06-24
KR20110091536A (ko) 2011-08-11
HN2011001614A (es) 2014-03-03
CA2746701A1 (fr) 2010-06-17
CN102317302A (zh) 2012-01-11
IL213380A (en) 2014-02-27
AU2009326907A1 (en) 2011-06-30
SV2011003937A (es) 2012-01-20
WO2010067008A2 (fr) 2010-06-17
JP2012511552A (ja) 2012-05-24
CR20110317A (es) 2011-10-18
NZ593340A (en) 2012-12-21
IL213380A0 (en) 2011-07-31
US8440634B2 (en) 2013-05-14
CN102317302B (zh) 2014-02-12

Similar Documents

Publication Publication Date Title
ECSP099330A (es) Compuesto de indol
BRPI1011683B8 (pt) derivados de isoquinolina substituída, suas composições farmacêuticas e seus usos
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
HN2009000502A (es) DERIVADOS DE 2- ARIL-6-FENIL-IMIDAZO[ 1,2-a] PIRIDINAS SU PREPARACION Y SU APLICACION EN TERAPEUTICA
BRPI1009212B8 (pt) Composto de piperazina capaz de inibir a prostaglandina d sintase, seus usos e composição farmacêutica
MX365721B (es) Aplicaciones y metodos para estabilidad de espuma mejorada.
BR112014001018A2 (pt) derivado de azabenzimidazol tendo atividade de ativação de ampk
CO6351789A2 (es) Derivados de carbamatos de alquiltiazoles, su preparacion y su aplicacion en terapeutica
TW201129564A (en) Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof
ECSP099216A (es) Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112013024223A2 (pt) composto de poliéter, agente de cura usando o composto de poliéter, e método de produção do composto de poliéter
CU24030B1 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
CR11327A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
CR20120261A (es) Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica
BRPI1016069A8 (pt) Misturas de ésteres e composições compreendendo tais misturas de ésteres
MX337320B (es) Análogos halogenados de agentes anti-fibroticos.
CU20100157A7 (es) Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112013008675A2 (pt) métodos e composições para o tratamento de diabetes e dislipidemia
CO6150157A2 (es) Derivados de 7-alquinil-1,8- naftiridonas su preparacion y su aplicacion en terapeutica
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
BR112012020703A2 (pt) composição para o controle de pragas
BR112016011778A2 (pt) Pirazol fluorofenila, seus usos, e composição farmacêutica
BR112015016647A2 (pt) processo para a preparação de um derivado de fluorlactona
BR112014018985A8 (pt) Método para preparar um composto